Microparticle immune response modifier shows broad effects against recurrent or metastatic cancer
Tuesday, April 21, 2009 - 09:56
in Health & Medicine
DENVER, CO and AUCKLAND, NZ (April 21, 2009) - MIS416, a novel microparticle-based immune response modifier, demonstrated the ability to significantly reduce the number and size of metastatic tumor